全文获取类型
收费全文 | 8472篇 |
免费 | 648篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 208篇 |
妇产科学 | 61篇 |
基础医学 | 979篇 |
口腔科学 | 187篇 |
临床医学 | 592篇 |
内科学 | 2486篇 |
皮肤病学 | 379篇 |
神经病学 | 441篇 |
特种医学 | 392篇 |
外科学 | 1492篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 207篇 |
眼科学 | 89篇 |
药学 | 454篇 |
中国医学 | 9篇 |
肿瘤学 | 1112篇 |
出版年
2024年 | 9篇 |
2023年 | 145篇 |
2022年 | 292篇 |
2021年 | 457篇 |
2020年 | 220篇 |
2019年 | 296篇 |
2018年 | 370篇 |
2017年 | 333篇 |
2016年 | 354篇 |
2015年 | 336篇 |
2014年 | 430篇 |
2013年 | 446篇 |
2012年 | 757篇 |
2011年 | 763篇 |
2010年 | 393篇 |
2009年 | 316篇 |
2008年 | 516篇 |
2007年 | 578篇 |
2006年 | 499篇 |
2005年 | 463篇 |
2004年 | 376篇 |
2003年 | 297篇 |
2002年 | 239篇 |
2001年 | 33篇 |
2000年 | 26篇 |
1999年 | 29篇 |
1998年 | 31篇 |
1997年 | 27篇 |
1996年 | 19篇 |
1995年 | 16篇 |
1994年 | 14篇 |
1993年 | 17篇 |
1992年 | 16篇 |
1991年 | 13篇 |
1990年 | 12篇 |
1989年 | 11篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1974年 | 1篇 |
1973年 | 3篇 |
排序方式: 共有9193条查询结果,搜索用时 15 毫秒
991.
Naotaka Okamoto Naoki Mori Yasuharu Lee Daisuke Nakamura Takahiro Yoshimura Masayuki Taniike Nobuhiko Makino Hiroyasu Kato Yasuyuki Egami Ryu Shutta Jun Tanouchi Yoshio Yamada Masami Nishino 《Journal of Echocardiography》2012,10(3):95-97
We describe a case of cardiac masses (high- and iso-echoic mass) which were detected by echocardiography in a 57-year-old man with cerebral infarction. Because he refused both biopsy and surgery, the patient was treated with an anticoagulant and antibiotic in our outpatient clinic. During 3-year follow-up, the iso-echoic mass disappeared and the high-echoic mass did not change. Thus, we considered the iso-echoic mass a thrombus and the high-echoic mass a benign tumor. Cardiac computed tomography revealed that the high-echoic mass had extensive calcifications like phleboliths, and magnetic resonance imaging pattern coincided with that of hemangiomas. We conclude that the benign tumor/high-echoic mass might be a vascular malformation. 相似文献
992.
993.
Shunsuke Yamane Norio Harada Akihiro Hamasaki Atsushi Muraoka Erina Joo Kazuyo Suzuki Daniela Nasteska Daisuke Tanaka Masahito Ogura Shin‐ichi Harashima Nobuya Inagaki 《Journal of diabetes investigation.》2012,3(1):80-85
Aims/Introduction: Gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are the major incretins; their secretion after various nutrient loads are well‐evaluated in Caucasians. However, little is known of the relationship between incretin secretion and differing nutritional loading in Japanese subjects. In the present study, we evaluated GIP and GLP‐1 secretion in Japanese subjects with normal glucose tolerance (NGT) after glucose loading (75 g glucose and 17 g glucose) and meal ingestion. Materials and Methods: A total of 10 Japanese NGT subjects participated in 75 g oral glucose tolerance test (OGTT), 17 g OGTT and meal tolerance test (MTT). Plasma glucose (PG), serum insulin (IRI), serum C‐peptide (CPR), plasma total GIP, and plasma total GLP‐1 levels during OGTT and MTT were determined. Results: Area under the curve (AUC)‐GIP was increased in proportion to the amount of glucose, and was highest in MTT, showing that GIP secretion is also stimulated by nutrients other than glucose, such as lipid. In contrast, although the larger glucose load tended to induce a larger GLP‐1 release, AUC‐GLP‐1 was not significantly different among the three loading tests (75 g OGTT, 17 g OGTT, MTT) irrespective of the kind or amount of nutrition load. Conclusions: Our results suggest that nutritional composition might have a greater effect on GIP secretion than that on GLP‐1 secretion in Japanese NGT subjects . (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00143.x, 2012) 相似文献
994.
Daisuke Yabe Koin Watanabe Kenji Sugawara Hitoshi Kuwata Yuka Kitamoto Kazu Sugizaki Shuichi Fujiwara Masahiro Hishizawa Takanori Hyo Kyoko Kuwabara Kayo Yokota Masahiro Iwasaki Naomi Kitatani Takeshi Kurose Nobuya Inagaki Yutaka Seino 《Journal of diabetes investigation.》2012,3(1):70-79
Aims/Introduction: The effectiveness of incretin‐based therapies in Asian type 2 diabetes requires investigation of the secretion and metabolism of glucose‐dependent insulinotropic polypepide (GIP) and glucagon‐like peptide 1 (GLP‐1). Plasma extractions have been suggested to reduce variability in intact GLP‐1 levels among individuals by removing interference that affects immunoassays, although no direct demonstration of this method has been reported. We have evaluated the effects of ethanol and solid‐phase extractions on incretin immunoassays. We determined incretin levels during meal tolerance tests in Japanese patients with type 2 diabetes and characterized predictors for incretin secretion. Materials and Methods: Japanese patients with type 2 diabetes (23 anti‐diabetic drug‐naïve and 18 treated with sulfonylurea [SU] alone) were subjected to meal tolerance tests, and incretin levels were determined by immunoassays with or without extraction. Results: Intact GLP‐1 levels determined by an intact GLP‐1 immunoassay with ethanol and solid‐phase extractions were lower than those determined without extraction. Intact GLP‐1 levels determined by the extractions were highly correlated with each other, much more so than the levels with and without extraction. Total GLP‐1 was unaffected by extractions, showing that extractions remove interference only in the case of intact GLP‐1. Incretin secretion after meal ingestion was similar between drug‐naïve and SU‐treated patients. Fasting and postprandial GLP‐1 levels were correlated positively with fasting free fatty acids and negatively with dipeptidyl peptidase‐4 activity. Conclusions: Ethanol and solid‐phase extractions remove interference for intact GLP‐1 immunoassay. SU showed little effect on incretin secretion. GLP‐1 and GIP secretion were predicted by different factors. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00141.x, 2012) 相似文献
995.
Shinji Kume Takashi Uzu Chieko Takagi Morihiro Kondo Tomoko Okabe Shin‐ichi Araki Keiji Isshiki Naoko Takeda Keiko Kondo Masakazu Haneda Daisuke Koya Yoshihiko Nishio Atsunori Kashiwagi Hiroshi Maegawa 《Journal of diabetes investigation.》2012,3(3):298-301
Anti‐diabetic agent‐related hypoglycemia is a serious complication in type 2 diabetic patients on hemodialysis. Therefore, we assessed the efficacy and tolerability of 24 weeks of monotherapy with vildagliptin, a dipeptidyl peptidase four inhibitor, which is a new class of antidiabetic agent. This open‐label, single‐arm clinical trial was performed on 26 patients on hemodialysis. The primary assessments were changes in postprandial glucose level and glycated albumin (GA). During the study, three patients dropped out, and data from 23 patients were analyzed. Significant reductions were seen in postprandial glucose (−2.60 ± 3.80 mmol/L, P < 0.001) and GA (−2.59 ± 2.33%, P < 0.001) levels. No serious drug‐related adverse events were observed. Vildagliptin monotherapy can be recommended for glycemic control in type 2 diabetic patients on hemodialysis. This trial was registered with the University Hospital Medical Information Network (no. UMIN000003661). (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00169.x, 2011) 相似文献
996.
Kenichi Sakurai Eun Young Lee Asuka Morita Sadao Kimura Harukiyo Kawamura Atsushi Kasamatsu Masashi Shiiba Daisuke Yabe Koutaro Yokote Takashi Miki 《Journal of diabetes investigation.》2012,3(2):156-163
Aims/Introduction: Oral ingestion of carbohydrate triggers secretion of glucagon‐like peptide (GLP)‐1, which inhibits the postprandial rise in blood glucose levels. However, the mechanism of carbohydrate‐induced GLP‐1 secretion from enteroendocrine L cells remains unclear. In the present study, GLP‐1 secretion was examined by meal tolerance tests of healthy Japanese volunteers. Materials and Methods: Twenty‐one healthy Japanese men participated in the study. The meal tolerance test was performed with modified nutrient compositions, with or without pretreatment with the α‐glucosidase inhibitor acarbose, or with substitution of sucrose with an equivalent dose of sweeteners in the meal. Blood concentrations of glucose, insulin, GLP‐1, and apolipoprotein (Apo) B‐48 were measured. Results: GLP‐1 secretion started concomitant with the increase in blood glucose levels 10 min after meal ingestion. Insulin secretion started at 5 min, before the increase in blood glucose levels, reflecting the contribution of direct nutrient stimulation on the former parameter and neural regulation in the latter. Carbohydrate retention in the gut lumen induced by acarbose pretreatment extended postprandial GLP‐1 secretion and negated the increase in serum ApoB‐48 levels. GLP‐1 secretion was markedly decreased by a reduction in the amount of sucrose in the meal and was not restored by an equivalent dose of sweeteners used to compensate for the sweet taste. Conclusions: The results indicate that direct stimulation of L cells with sugar, but not sweetener, is required for carbohydrate‐induced GLP‐1 secretion. In addition, inhibition of digestion of dietary carbohydrate by α‐glucosidase inhibitors may prevent postprandial hyperglycemia by increasing GLP‐1 secretion and by inhibiting glucose absorption. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00163.x, 2011) 相似文献
997.
Takashi Ishikawa Daisuke Shimizu Ayako Kito Ikuko Ota Takeshi Sasaki Mikiko Tanabe Akimitsu Yamada Hitoshi Arioka Satoru Shimizu Junichi Wakasugi Ryutaro Mori Takashi Chishima Yasushi Ichikawa Itaru Endo 《Journal of thoracic disease》2012,4(6):650-654
Breast cancer is the most common type of cancer in women. However, it is very rarely manifested as hematologic disorders. A 35-year-old woman was admitted because of disseminated intravascular coagulation. Examinations revealed the presence of breast cancer in her left breast; therefore, paclitaxel was administered weekly. Although disseminated intravascular coagulation was controlled, pulmonary dysfunction due to lymphangitis carcinomatosa suddenly occurred 10 weeks after treatment. Pulmonary dysfunction was effectively treated with epirubicin and cyclophosphamide. Twenty-three weeks after treatment, the patient developed liver dysfunction accompanied with jaundice due to progressive metastatic lesions in the liver; liver dysfunction improved after the administration of vinorelbine. Subsequently, because of the recurrence of pulmonary dysfunction, rechallenge with epirubicin and cyclophosphamide was performed and was effective; however, this therapy was discontinued because of its adverse effects. She expired of liver failure 33 weeks after the occurrence of disseminated intravascular coagulation. Metastatic tumors in the bone marrow, lung, and liver showed different sensitivities to different anti-cancer agents. We report a case of breast cancer manifested by hematologic disorders which was treated by a sequential chemotherapy.KEY WORDS : Breast cancer, disseminated intravascular coagulation, multiple organ metastases 相似文献
998.
Abo D Hasegawa Y Sakuhara Y Terae S Shimizu T Tha KK Tanaka E Hirano S Kondo S Shirato H 《Journal of hepato-biliary-pancreatic sciences》2012,19(4):431-437
Purpose
To describe the feasibility of a dual microcatheter-dual interlocking detachable coil (DMDI) technique for preoperative embolization of the common hepatic artery (CHA) in preparation for distal pancreatectomy with en bloc celiac axis resection (DP-CAR) for locally advanced pancreatic body cancer.Methods
From January 2007 to December 2009, 26 patients underwent embolization of the CHA by the DMDI technique. We compared the results with those of 37 patients in whom the CHA was embolized by conventional techniques from August 1998 to February 2007.Results
With the DMDI technique, no coil migration or other embolization-related complications occurred. The success rate was 100%. The rate of embolization-related complications was significantly lower in the DMDI embolization group (0%) than in the conventional embolization group (24.3%) (P?=?0.008). The frequency of improper positioning of the embolic material necessitating its removal during DP-CAR was significantly lower in the DMDI embolization group (10%) than in the conventional embolization group (37.5%) (P?=?0.044).Conclusion
The DMDI technique allows the development of collateral pathways, reduces the surgeon's burden in ligating the distal CHA, and prevents coil migration. For these reasons, we believe that this technique is feasible for embolization of the CHA in preparation for DP-CAR for locally advanced pancreatic body cancer. 相似文献999.
Shoichi Nishise Takeshi Sato Yu Sasaki Ko Nagino Daisuke Iwano Takao Yaoita Kazuya Yoshizawa Yuko Nishise Hiroaki Takeda 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2012,16(5):449-455
Interleukin (IL)‐10 is an anti‐inflammatory cytokine mainly produced by monocytes and is essential for the induction of anti‐inflammatory intestinal macrophages with macrophage colony‐stimulating factor (M‐CSF). Thus, IL‐10‐ and M‐CSF‐rich conditions in colonic tissues seem to contribute to the improvement of pathological conditions in patients with inflammatory bowel diseases (IBD). We have already reported that ulinastatin, a serine protease inhibitor, increases M‐CSF production during granulocyte/monocyte (GM) adsorption to cellulose acetate (CA) beads (carriers for Adacolumn therapy). However, the effects of ulinastatin on IL‐10 production have not been clarified. The aim of the present study was to clarify the effects of ulinastatin on IL‐10 production during GM adsorption by in vitro experiments. Peripheral blood was divided into four groups: (Control) no ulinastatin added, no contact with CA beads; (1) no ulinastatin added, contact with CA beads; (2) ulinastatin added, no contact with CA beads; and (3) ulinastatin added, contact with CA beads. After incubation, IL‐10 in the plasma was measured. Compared with the level in the Control group, plasma IL‐10 was significantly higher only in group 3, in which ulinastatin was added in the presence of CA beads, but did not increase in the absence of CA beads. These results suggest that ulinastatin synergistically increases IL‐10 production with monocyte adsorption stimuli. By increasing not only M‐CSF but also IL‐10, a combination of ulinastatin and Adacolumn therapy may improve clinical efficacy for the treatment of IBD in terms of the induction of anti‐inflammatory intestinal macrophages. 相似文献